Official websites use .gov
A
.gov
website belongs to an official government organization in the
United States.
Secure .gov websites use HTTPS
A
lock
(
) or
https://
means you’ve safely connected to the .gov website. Share sensitive
information only on official, secure websites.
PubMed ID:
29378307
Public Release Type:
Journal
Publication Year: 2018
Affiliation: Gastroenterology, University of California San Francisco, San Francisco, California; Gastroenterology, University of California San Diego, San Diego, California. Electronic address: v1ajmera@ucsd.edu.; Epidemiology, Johns Hopkins, Baltimore, Maryland.; Epidemiology, Johns Hopkins, Baltimore, Maryland.; Pathology, University of California San Francisco, San Francisco, California.; Gastroenterology, University of California San Diego, San Diego, California.; Pathology, National Cancer Institute, Bethesda, Maryland.; Division of Gastroenterology and Hepatology, Saint Louis University, St. Louis, Missouri.; Gastroenterology, University of California San Francisco, San Francisco, California.
DOI:
https://doi.org/10.1016/j.cgh.2018.01.026
Authors:
Ajmera Veeral, Belt Patricia, Wilson Laura A., Gill Ryan M., Loomba Rohit, Kleiner David E., Neuschwander-Tetri Brent A., Terrault Norah
Request IDs:
21513
,
21515
Studies:
The Farnesoid X Receptor Ligand Obeticholic Acid in NASH Treatment
Cross-sectional studies of patients with nonalcoholic fatty liver disease (NAFLD) have reported a lower prevalence of severe disease among modest drinkers compared to non-drinkers. We collected data from adult participants in the Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) to evaluate the longitudinal association between modest use of alcohol and histology findings in patients with NAFLD, using paired liver biopsies collected more than 1 year apart.
